Masimo said it received Food and Drug Administration approval for its Stork baby monitor for purchase without a prescription. The over-the-counter system offers the same pulse oximetry technology as ...

IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI), a global leader in noninvasive monitoring technologies, today announced the full U.S. market release of the Stork smart home baby monitoring ...

Amsterdam, the Netherlands and Irvine, California, U.S. – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Masimo (NASDAQ: MASI), a global medical technology company, ...

IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI), a global leader in innovative monitoring technologies used in top hospitals, announced today FDA clearance of Stork™, a revolutionary baby ...

It’s a baby (monitor) boom! Shortly after Owlet secured a long-awaited FDA clearance for its baby-monitoring “sock” equipped with pulse oximetry technology—which was followed just last month by ...

Per Masimo, “Radius-7 is lightweight, weighing only 0.34 lbs, and attaches to the arm, thus allowing untethered monitoring whether a patient is in or out of bed – which also reduces the need for ...

MASI's strong Q3 2025 results, FDA clearance and partnerships fuel growth hopes, but SET dependence and reimbursement risks ...

Masimo Corporation MASI recently announced the full U.S. market release of the Stork smart home baby monitoring system. The Stork Vitals+, Vitals, and Camera combinations are now available for ...

Universal Surveillance Monitoring with Masimo SET ® Pulse Oximetry and Patient SafetyNet™ – Repeatedly Shown to Improve Patient Outcomes and Save Lives – Also Projected to Yield Significant Cost ...

Masimo (NASDAQ: MASI) today announced the findings of a study published in the Journal of Patient Safety in which Dr. George Blike and colleagues at Dartmouth-Hitchcock Medical Center in New Hampshire ...